苏州市重点药品监控效果评估与思考  

Evaluation and Consideration on the Effect of Key Monitoring Drugs in Suzhou

作　　者：席晓宇[1] 卢梦情 裴佩 陆倩妮 江苏省医保研究会课题组 Xi Xiaoyu;Lu Mengqing;Pei Pei;Lu Qianni;Subject Group of Jiangsu Medical Insurance Research Association(China Pharmaceutical University,Nanjing,211198;Jiangsu Medical Insurance Research Association,Nanjing,210003)

机构地区：[1]中国药科大学,南京211198 [2]江苏省医疗保险研究会,南京210003

出　　处：《中国医疗保险》2020年第6期39-43,共5页China Health Insurance

基　　金：2018年江苏省医疗保险研究会委托课题:医保药品费用支出对医保基金的影响及重点监控品种研究。

摘　　要：本文选择苏州作为重点药品监控政策样本地区,遴选重点监控样本药品,探讨重点药品监控对医保基金的影响,并在此基础上分析重点监控药品使用情况及存在问题,以期为相关政策完善与推进提供依据。This paper selects Suzhou as the sample area of key monitoring drugs policies, and discusses the impact of key monitoring drugs on medical insurance fund by selecting sample drugs. Based on this, it analyzes the use of key monitoring drugs and existing problems, in order to provide basis for the improvement and promotion of relevant policies.

关 键 词：重点药品 监控 医保基金 评估与思考 苏州 

分 类 号：F840.684[经济管理—保险] C913.7[社会学]